University of Trier

Leadership Change at Allianz Central Europe

Retrieved on: 
Monday, December 11, 2023
Professional Services, Insurance, Finance, Landesbank Baden-Württemberg, University of Trier, Economics, LBBW, Head, CFO, Multimedia, Culture, Allianz, Marketing, Office, University, Landesbank, SE, Personality, Allianz Global Investors, Management, Central European, Central Europe

Allianz SE today announced leadership changes that will take effect from January 1, 2024:

Key Points: 
  • Allianz SE today announced leadership changes that will take effect from January 1, 2024:
    This press release features multimedia.
  • View the full release here: https://www.businesswire.com/news/home/20231211051237/en/
    Nina Klingspor will succeed Petros Papanikolaou as CEO of Allianz Central Europe (Photo: Allianz)
    Nina Klingspor, currently CEO of Allianz Private Krankenversicherungs-AG, Allianz private health insurance business in Germany (APKV), will be appointed as the new CEO of Central Europe for Allianz Group, subject to approval by the relevant corporate bodies.
  • Allianz Central Europe is a regional entity with responsibility for Allianz national businesses in 11 countries in Central and Eastern Europe.
  • Klaus-Peter Roehler, Member of the Allianz SE Board of Management, said “I want to thank Petros for the outstanding work he has done at Allianz Central Europe, his establishment of the regional entity and his successful transformation of the regional model.

PM International celebrates its 30th anniversary

Retrieved on: 
Tuesday, June 27, 2023
Mannheimer Rosengarten, PM, University, Magic, Speech, SAP Arena, Research, PM-International, Athlete, World Vision International, Beauty, Child, Charity, University of Trier, Health, World Congress, Very important person, Nightclub, Online shopping

An evening gala in the Rosengarten Mannheim opened the celebrations of the anniversary weekend on Friday.

Key Points: 
  • An evening gala in the Rosengarten Mannheim opened the celebrations of the anniversary weekend on Friday.
  • They were able to experience numerous show acts, of which Norwegian singer Angelina Jordan was the highlight of the evening.
  • On Saturday, the 30th Anniversary World Congress in the SAP Arena followed.
  • The anniversary event began with the appearance of company CEO and Founder Rolf Sorg.

PM International celebrates its 30th anniversary

Retrieved on: 
Tuesday, June 27, 2023
Mannheimer Rosengarten, PM, University, Magic, Speech, SAP Arena, Research, PM-International, Athlete, World Vision International, Beauty, Child, Charity, University of Trier, Health, World Congress, Very important person, Nightclub, Online shopping

An evening gala in the Rosengarten Mannheim opened the celebrations of the anniversary weekend on Friday.

Key Points: 
  • An evening gala in the Rosengarten Mannheim opened the celebrations of the anniversary weekend on Friday.
  • They were able to experience numerous show acts, of which Norwegian singer Angelina Jordan was the highlight of the evening.
  • On Saturday, the 30th Anniversary World Congress in the SAP Arena followed.
  • The anniversary event began with the appearance of company CEO and Founder Rolf Sorg.

Tessa Therapeutics Appoints Thomas Willemsen as President and CEO

Retrieved on: 
Monday, August 22, 2022
CEO, Technology, Hodgkin lymphoma, Safety, European Medicines Agency, Commercial, Takeda Pharmaceutical Company, University of Trier, TT11, Therapy, Vaccine, Emerging market, GSK, Board, Nivolumab, Sun, Optimism, US, Â, Lead, Senior, Hematological Cancer Research Investment and Education Act, CD30, PRIME, Lists of diseases, Lymphatic system, Intercontinental, MBA, GlaxoSmithKline, GLOBE, Leadership, FDA, Company, General manager, Cancer, Taiwan, Merck, Marketing, Clinical trial, Private Securities Litigation Reform Act, Trial of the century, Patient, Pharmaceutical industry, Management, Oncology, Asia-Pacific, Takeda

SINGAPORE, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced the appointment of Thomas Willemsen as its President and Chief Executive Officer effective October 1, 2022. Mr. Willemsen has also been named as a member of Tessa’s Board of Directors.

Key Points: 
  • SINGAPORE, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced the appointment of Thomas Willemsen as its President and Chief Executive Officer effective October 1, 2022.
  • Mr. Willemsen brings more than 25 years of experience to Tessa with extensive international management and leadership experience in the pharmaceutical industry.
  • John Ng, who had served as Tessas acting CEO since November 2021, will continue as the companys Chief Technical Officer.
  • Tessa Therapeutics is a clinical-stage biotechnology company developing next-generation cell therapies for the treatment of hematological cancers and solid tumors.